Related Experiment Video
Updated: Mar 11, 2026
06:48
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
22.3K
[Gene Therapy for Inherited RETINAL AND OPTIC NERVE Disorders: Current Knowledge]
Summary
Gene therapy offers a promising treatment for inherited retinal disorders and optic nerve conditions. Current clinical trials are evaluating safety and efficacy for diseases like Leber congenital amaurosis 2 and Leber hereditary optic neuropathy.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Gene therapy is emerging as a significant therapeutic strategy for monogenic retinal diseases and optic nerve disorders.
- The number of genes targeted for gene-based therapies is rapidly expanding, indicating progress in the field.
Purpose of the Study:
- To comprehensively review current gene therapy clinical trials for monogenic and optic nerve disorders.
- To highlight the status and potential of gene-based treatments for various inherited eye conditions.
Main Methods:
- Review of registered gene therapy clinical trials for inherited retinal and optic nerve disorders.
- Analysis of trial phases (I, II, and III) focusing on efficacy and safety assessments.
Main Results:
- Clinical trials are underway for Leber congenital amaurosis 2 (LCA2), retinitis pigmentosa 38, Usher syndrome 1B, Stargardt disease, choroideremia, achromatopsia, Leber hereditary optic neuropathy (LHON), and X-linked retinoschisis.
- Gene therapy for LCA2 (RPE65) and LHON (MT-ND4) have advanced to Phase III, while others are in Phase I and II investigation.
Conclusions:
- Gene therapy is a highly promising treatment for inherited retinal disorders due to the retina's accessibility and ease of monitoring.
- Accurate clinical and molecular genetic diagnosis is crucial for the successful development and application of novel gene therapy approaches.
